POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Potassium Phosphates In 0.9% Sodium Chloride patents expire, and when can generic versions of Potassium Phosphates In 0.9% Sodium Chloride launch?
Potassium Phosphates In 0.9% Sodium Chloride is a drug marketed by Amneal and is included in one NDA.
The generic ingredient in POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE is potassium phosphate, dibasic; potassium phosphate, monobasic. There are two hundred and forty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the potassium phosphate, dibasic; potassium phosphate, monobasic profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE?
- What are the global sales for POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE?
- What is Average Wholesale Price for POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE?
Summary for POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE at DailyMed |
Recent Clinical Trials for POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mahidol University | N/A |
See all POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE clinical trials
Pharmacology for POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE | potassium phosphate, dibasic; potassium phosphate, monobasic | SOLUTION;INTRAVENOUS | 218343-001 | Jul 26, 2024 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
